Evidence map›Paper›PMID 31443885›Full record

ArticleJournal of substance abuse treatment2019

Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

Mance E Buttram, Steven P Kurtz, Matthew S Ellis, Theodore J Cicero

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mance E ButtramCenter for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, 7255 NE 4th Avenue, Suite 112, Miami, FL 33138, USA. Electronic address: mance.buttram@nova.edu.
Steven P KurtzCenter for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, 7255 NE 4th Avenue, Suite 112, Miami, FL 33138, USA.
Matthew S EllisWashington University, Department of Psychiatry, Campus Box 8134, 600 S. Euclid Avenue, St. Louis, MO 63110, USA.
Theodore J CiceroWashington University, Department of Psychiatry, Campus Box 8134, 600 S. Euclid Avenue, St. Louis, MO 63110, USA.

Funding

An Examination of Gabapentin/Pregabalin Initiation, Misuse, and ConsequencesR03DA043613 · NIDA · NOVA SOUTHEASTERN UNIVERSITY · PI BUTTRAM, MANCE E. · 2017 to 2017
$109k
NIDA NIH HHS R03 DA043613
6 · The paper itself

Abstract

backgroundGabapentin, a prescription medication approved for the treatment of seizures and neuralgia, is often prescribed off-label for substance use treatment, mental health problems, and pain. Emerging reports also suggest it is misused for the purpose of getting high. The present study examines substance abuse treatment provider key informants' experiences with gabapentin prescribed to clients in treatment. The focus of this exploratory study is to ascertain how gabapentin is used in these settings and the benefits and risks for clients.

methodsKey informants from South Florida participated in confidential, in-depth interviews (N = 12). Data analyses included descriptive and in vivo coding schemes and employed a descriptive qualitative approach.

resultsAll key informants recognized the benefits of prescribing gabapentin to clients in treatment for problems related to withdrawal symptoms, mental distress and pain. At the same time, half of participants described gabapentin misuse among clients and four key informants described such misuse as a first marker of relapse. Key informants also stated that more research must be done about how to use gabapentin effectively in treatment settings.

conclusionsThese findings illustrate the lack of clarity about the efficacy of administration of gabapentin in treatment settings. Additional research about how to best use gabapentin, for whom it may be beneficial, and the effect of prescribed gabapentin on addiction recovery is needed.

Indexed as

Off-Label UsePrescription Drug MisuseAnalgesicsFloridaGabapentinHealth PersonnelHumansInterviews as TopicPainQualitative ResearchSubstance-Related DisordersSubstance Withdrawal SyndromeAnalgesicsGabapentinGabapentinMisuseQualitativeSubstance abuse treatment

Identifiers

PMID31443885
PMCPMC6709710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.